Endometriosis

Other OA: closed CC0 ⤵ 15 in-corpus citations
⚙ AI-generated summary by qwen3.7-flash+body, 2026-11-21 ⓘ

This BMJ article provides an update on endometriosis, highlighting the condition as easily missed and discussing aspects of reproductive medicine and pain management.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-11-21 · read from full text ⓘ

This paper examines the frequent misdiagnosis and significant delays in identifying endometriosis, highlighting that average diagnostic intervals reach seven to eight years despite the condition affecting one in ten individuals. The authors attribute these delays to non-specific symptoms like pelvic pain and infertility, which are often dismissed or attributed to other conditions, alongside a lack of reliable non-invasive testing methods and inconsistent clinical guidelines. Key limitations noted include the uncertainty regarding whether earlier treatment alters the natural history of the disease or prevents chronic pain syndromes. This paper is centrally about endometriosis — specifically focusing on the barriers to diagnosis and the resulting socioeconomic and psychological burden of the condition.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 29,632 characters · extracted from oa-pdf · 2 sections · click to expand

Keywords

Reproductive medicine, Pain https://mc.manuscriptcentral.com/bmj BMJ Confidential: For Review Only 1 1 BMJ: Easily Missed: Endometriosis, an update 2 Authors 3 Louie Ye1,2 4 Job title: RANZCOG Trainee/Clinical Fellow 5 Lucy H R Whitaker3 6 Job title: NES/CSO Clinical Lecturer in Obstetrics & Gynaecology 7 Rebecca L Mawson4 8 Job title: GP & Academic Training Fellow 9 Martha Hickey1,2 10 Job title: Professor of Obstetrics and Gynaecology 11 12 Affiliations 13 1. The Royal Women’s Hospital, Melbourne, Victoria, Australia 14 2. The Department of Obstetrics and Gynaecology, University of Melbourne and the 15 Royal Women’s Hospital, Victoria, Australia 16 3. MRC Centre for Reproductive Health, Queen's Medical Research Institute, University 17 of Edinburgh, 49 Little France Crescent, EH16 4TJ 18 4. The Academic Unit of Primary Medical Care, The University of Sheffield, Samuel Fox 19 House, Sheffield, S5 7AU, UK. 20 21 Corresponding author: [email protected] 22 23 Declarations 24 The Corresponding Author has the right to grant on behalf of all authors and does grant on 25 behalf of all authors, a worldwide licence to the Publishers and its licensees in perpetuity, in 26 all forms, formats and media (whether known now or created in the future), to i) publish, 27 reproduce, distribute, display and store the Contribution, ii) translate the Contribution into 28 other languages, create adaptations, reprints, include within collections and create 29 summaries, extracts and/or, abstracts of the Contribution, iii) create any other derivative 30 work(s) based on the Contribution, iv) to exploit all subsidiary rights in the Contribution, v) 31 the inclusion of electronic links from the Contribution to third party material where-ever it 32 may be located; and, vi) licence any third party to do any or all of the above. 33 34 We have read and understood the BMJ policy on declaration of interests and declare the 35 following interests: None 36 37 Those named as authors have fulfilled all 4 ICMJE authorship criteria. 38 39 Within our article, we use the terms ‘women’ and ‘women’s health’. However, we 40 acknowledge that it is necessary for all assigned female at birth, including those whose gender 41 identity does not align with the sex they were assigned at birth, to access evidence-based care 42 in order to maintain their gynaecological health and reproductive wellbeing. 43 44 45 46 47 Page 1 of 10 https://mc.manuscriptcentral.com/bmj BMJ 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 Confidential: For Review Only 2 48 Case presentation 49 A 24-year-old woman presents to a new GP with several years of pain during sexual 50 intercourse and increasingly painful periods affecting her mood, relationships and work. The 51 pain persisted despite simple analgesia. She has had multiple contacts with healthcare 52 professionals without a diagnosis or effective management. Her new GP suspects 53 endometriosis. A transvaginal ultrasound (TVUS) and a three-month trial of combined oral 54 contraceptive (COCP) is recommended. No pathology is identified on ultrasound. After three 55 months, there was little improvement, and a gynaecology referral was offered. Subsequent 56 laparoscopy reveals superficial peritoneal endometriosis, and the patient opted for 57 concurrent excisional surgery with insertion of a levonorgestrel-releasing intrauterine 58 system, a choice reflecting her previous treatment experiences and current contraceptive 59 requirements. 60 61 What is it? 62 63 Endometriosis is defined as the “presence of endometrial-like tissue outside the uterus”(1). 64 There are three sub-types: Superficial peritoneal, deep and ovarian (endometrioma cysts) 65 though symptom severity and disease sub-type and extent are commonly discordant (1). 66 Less frequently, endometriosis occurs in other anatomical locations such as the thorax or 67 previous surgical incision sites (1). 68 69 Estimates of disease prevalence vary widely due to inconsistent presentation compounded 70 by diagnostic challenges. In particular, the requirement of laparoscopy to make a diagnosis. 71 The estimated population prevalence of endometriosis is 1 in 10 (2) but is higher in selected 72 populations. For example in those with subfertility prevalence may be up to 50% (3). 73 74 Typical gynaecological presentations include painful periods and sub-fertility (1,4). Other 75 symptoms include pain with sex and with defecation or urination which may be cyclical, and 76 systemic manifestations such as fatigue (1,4,5). Sensitisation of central pathways may lead 77 to chronic pain syndromes (6). Long-term consequences include impaired quality of life, 78 anxiety, depression and self-harm(7,8). However, not all individuals with endometriosis 79 have pain symptoms, particularly in the context of sub-fertility. 80 81 Factors contributing to sub-fertility may include reduced ovarian reserve, altered 82 implantation and adhesion-related tubal occlusion, as well as decreased frequency of coitus 83 due to associated pain(9). Endometriosis is commonly missed, leading to diagnostic delays. 84 This article will discuss how the protean presenting symptoms and diagnostic criteria 85 contribute to this delay. Endometriosis associated infertility will not be explicitly discussed 86 because this diagnosis is commonly made during fertility investigations. 87 88 Why is it missed? 89 The average diagnostic delay is seven years from the onset of symptoms to definitive 90 diagnosis with variation between countries (10). In 2020, the UK diagnostic delay was eight 91 years, which is unchanged in a decade (11). An important contributing factor is the delay 92 between primary presentation and diagnostic testing (12–15). One third of patients had 93 consulted their GP six or more times before referral, with 39% having two or more 94 gynaecological referrals before a definitive diagnosis (14). Page 2 of 10 https://mc.manuscriptcentral.com/bmj BMJ 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 Confidential: For Review Only 3 95 Endometriosis is difficult to diagnose clinically as symptoms are both common and non- 96 specific(15,16) and may be attributed to other conditions (17). For example, endometriosis 97 may mimic or cause IBS, a common condition in primary care(17). The variable nature of 98 presenting symptoms may lead them to be dismissed as functional or psychosomatic 99 (12,13). Women consistently report difficulties in convincing doctors about the severity of 100 their symptoms. This is compounded by clinicians dismissing or normalising symptoms such 101 as painful periods (11,18). Affected women may also believe that their menstrual symptoms 102 are normal (15). Diagnostic delay is even more common in adolescents(19), possibly due to 103 a false belief that endometriosis takes time to cause symptoms after the onset of 104 menarche(20). Cultural barriers may lead to reluctance or difficulty in reporting menstrual 105 and sexual symptoms (11,18). The lack of reliable non-invasive tests likely contributes to 106 delays in diagnosis and treatment(21,22). This is intensified by the variation and 107 methodological quality of endometriosis guidelines leading to different diagnostic 108 criteria(23). 109 Why does it matter? 110 Endometriosis may cause considerable suffering, distress and economic hardship for 111 individuals(6,24). Diagnostic delays may have a significant impact socially and 112 psychologically (25) and longer delay is associated with more advanced disease (26). 113 Chronic pain may impair quality of life, reduce productivity and workforce participation, and 114 contribute to financial hardship (Figure 1)(6,7,11). In the UK, the economic impact of 115 endometriosis is estimated at around £8.2 billion per year, primarily due to absenteeism 116 from work and healthcare costs (27). Direct treatment costs are comparable to conditions 117 such as Type 2 diabetes or rheumatoid arthritis (27). 118 119 Around 30% of women with infertility have endometriosis (28), increasing to 50% in those 120 with regular menstrual cycles and male partners normospermia(3). Delayed diagnosis may 121 reduce the chance of pregnancy by 33% (29). 122 123 With such profound consequences for individuals and society, "reducing delayed diagnosis" 124 is a priority area for research (11,30). Early diagnosis and prompt treatment might mitigate 125 the psychosocial and economic burden associated with delayed management of 126 endometriosis-related pain (12,15,29). However, it is not known whether earlier treatment 127 affects the natural history of endometriosis or reduces the incidence of chronic pain 128 syndromes 129 130 How is it diagnosed? 131 There is a lack of consensus about how endometriosis should be diagnosed. In the UK, 132 guidelines from the National Institute for Health and Care Excellence (NICE) and the 133 European Society of Human Reproduction and Embryology (ESHRE) advise that laparoscopy 134 is the gold standard diagnostic tool with histological confirmation (4,13). Limited access and 135 cost of laparoscopy contribute to delayed diagnosis and others have argued that clinical and 136 radiographic features are sufficient particularly for ovarian and deep sub-types (18). 137 Improving diagnosis and non-invasive screening tools is a top 10 research priority for the UK 138 (30). 139 Page 3 of 10 https://mc.manuscriptcentral.com/bmj BMJ 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 Confidential: For Review Only 4 140 Clinical features 141 Initial suspicion and clinical diagnosis of endometriosis relies on a combination of clinical 142 history, physical examinations, and imaging findings. Isolated pelvic examination in primary 143 care is often uninformative (5). A normal pelvic exam or inability to perform an examination 144 should not delay gynaecological referral(4). 145 Management in primary care may include ruling out conditions such as pelvic infection, 146 pregnancy, and inflammatory or irritable bowel disease. Previous presentations may also be 147 informative. A study of primary care records found that women subsequently diagnosed 148 with endometriosis were likely to have had multiple consults with menstrual pain within a 149 12-month period, as well as gastrointestinal symptoms associated with menstruation (31). 150 Managing complexity and uncertainty within the initial presentations of endometriosis 151 symptoms underpins consultations in general practice(32). 152 Investigations 153 There are currently no biomarkers for endometriosis with adequate specificity or sensitivity, 154 although this is an active area of research (21)(33). NICE and ESHRE guide against measuring 155 Ca125 due to lack of sensitivity and specificity (4). NICE recommends transvaginal 156 ultrasound (TVUS) as first-line imaging for suspected endometriosis (4). TVUS may exclude 157 other potential conditions such as cysts and may identify ovarian endometriomas. 158 Specialists in TVUS report a sensitivity of 79% and specificity of 94% for deep endometriosis 159 and 3-D ultrasound may increase sensitivity to 87% (22,34). However, Access to specialist 160 ultrasonography is limited in most settings. 161 162 Where TVUS is declined or inappropriate trans-abdominal ultrasound should be offered but 163 has a lower sensitivity and specificity than TVUS (4). Ovarian and deep endometriosis may 164 be visible on MRI (22). However, only around 17-44% of women with endometriosis present 165 with endometriomas (35,36). 166 Laparoscopy for direct visualisation of lesions remains gold standard diagnostic tool(4,13). 167 However, access to laparoscopy contributes to the delay in diagnosis, is costly, invasive and 168 carries surgical risks (37). In view of this, laparoscopy may not be required for diagnosis if 169 imaging identifies endometriomas or deep disease. Similarly, laparoscopy may not be 170 indicated for women with symptoms controlled by medical therapy if the patient is in 171 agreement with a ‘working diagnosis’ of endometriosis(38). 172 How is it managed? 173 Management in primary and tertiary care should be holistic, addressing symptoms and 174 offering psychological support, individualised to patient wishes and fertility priorities. In 175 primary care, NICE recommends a 3-month trial of paracetamol or NSAIDs alone or 176 combined with a COCP or continuous progestogen for pain suggestive of endometriosis(39). 177 Patient Decision aids have been developed to support the choice of hormonal preparation 178 (4). 179 180 Gynaecology referral is recommended when this initial management is ineffective or 181 contraindicated. Women with severe or recurrent symptoms, endometriomas (>3cm), 182 urinary tract/bowel involvement or infertility plus symptoms of endometriosis should also 183 be referred to a specialist endometriosis centre if available(4). Medical treatments such as Page 4 of 10 https://mc.manuscriptcentral.com/bmj BMJ 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 Confidential: For Review Only 5 184 LNG-IUS and GnRHa may be used alone or in addition to surgery (pre- & post-operatively) to 185 manage pain and reduce recurrence (40,41). 186 187 Laparoscopic excisional/ablative surgery is the mainstay of surgical treatment. Complex 188 surgery for deep endometriosis involving the bowel, bladder or ureter is best managed 189 within a specialist endometriosis centre(42). The risk of serious surgical complications 190 depends on the extent, distribution and depth of disease, but is around 7% for surgical 191 resection of deep endometriosis(42). Surgery may not be definitive and up to 50% report 192 persistent symptoms at 5 years, indicating the importance of informed choice and follow-up 193 care (43,44). Surgery has not been shown to improve fertility(39). A 2020 systematic review 194 concluded that laparoscopic surgical management did not improve live birth rates and 195 ovarian surgery may impair fertility (43). There are currently ongoing clinical trials examining 196 the risks and benefits of sub-type specific surgery to improve pain, quality of life and fertility 197 outcomes to inform evidenced-base and joint-decision making. 198 199

References

200 1. Saunders PTK, Horne AW. Endometriosis: Etiology, pathobiology, and therapeutic 201 prospects. Vol. 184, Cell. 2021. 202 2. Eskenazi B, Warner ML. Epidemiology of endometriosis. Obstet Gynecol Clin North 203 Am. 1997;24(2):235–58. 204 3. Meuleman C, Vandenabeele B, Fieuws S, Spiessens C, Timmerman D, D’Hooghe T. 205 High prevalence of endometriosis in infertile women with normal ovulation and 206 normospermic partners. Fertil Steril. 2009 Jul;92(1):68–74. 207 4. National Institute for Health and Care Excellence - NICE. Endometriosis: diagnosis and 208 management. 2017. 209 5. RANZCOG. Endometriosis Clinical Practice Guideline Australia [Internet]. 2021 [cited 210 2022 Apr 19]. Available from: 211 https://ranzcog.edu.au/RANZCOG_SITE/media/RANZCOG-MEDIA/Women%27s 212 Health/Statement and guidelines/Clinical - Gynaecology/Endometriosis-clinical- 213 practice-guideline.pdf?ext=.pdf 214 6. Coxon L, Horne AW, Vincent K. Pathophysiology of endometriosis-associated pain: A 215 review of pelvic and central nervous system mechanisms. Best Pract Res Clin Obstet 216 Gynaecol. 2018 Aug 1;51:53–67. 217 7. Estes SJ, Huisingh CE, Chiuve SE, Petruski-Ivleva N, Missmer SA. Depression, Anxiety, 218 and Self-Directed Violence in Women With Endometriosis: A Retrospective Matched- 219 Cohort Study. Am J Epidemiol. 2021;190(5):843–52. 220 8. Nnoaham KE, Hummelshoj L, Webster P, D’Hooghe T, De Cicco Nardone F, De Cicco 221 Nardone C, et al. Impact of endometriosis on quality of life and work productivity: a 222 multicenter study across ten countries. Fertil Steril. 2011;96(2). 223 9. Tanbo T, Fedorcsak P. Endometriosis-associated infertility: aspects of 224 pathophysiological mechanisms and treatment options. Acta Obstet Gynecol Scand. 225 2017 Jun 1;96(6):659–67. 226 10. Zondervan KT, Becker CM, Missmer SA. Endometriosis. Longo DL, editor. N Engl J 227 Med. 2020 Mar 26;382(13):1244–56. 228 11. APPG. APPG on Endometriosis Inquiry Report 2020. Endometriosis in the UK: time for 229 change (October 2020) - Women’s health - Patient Safety Learning - the hub. 2020. Page 5 of 10 https://mc.manuscriptcentral.com/bmj BMJ 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 Confidential: For Review Only 6 230 12. Ballard K, Lowton K, Wright J. What’s the delay? A qualitative study of women’s 231 experiences of reaching a diagnosis of endometriosis. Fertil Steril. 2006 232 Nov;86(5):1296–301. 233 13. Dunselman GAJ, Vermeulen N, Becker C, Calhaz-Jorge C, D’Hooghe T, De Bie B, et al. 234 ESHRE guideline: management of women with endometriosis. Hum Reprod. 235 2014;29(3):400–12. 236 14. Pugsley Z, Ballard K. Management of endometriosis in general practice: the pathway 237 to diagnosis. Br J Gen Pract. 2007 Jun;57(539):470. 238 15. Staal AHJ, Van Der Zanden M, Nap AW. Diagnostic Delay of Endometriosis in the 239 Netherlands. Gynecol Obstet Invest. 2016 Jul 1;81(4):321–4. 240 16. Abbas S, Ihle P, Köster I, Schubert I. Prevalence and incidence of diagnosed 241 endometriosis and risk of endometriosis in patients with endometriosis-related 242 symptoms: findings from a statutory health insurance-based cohort in Germany. Eur J 243 Obstet Gynecol Reprod Biol. 2012;160(1):79–83. 244 17. Ballard KD, Seaman HE, De Vries CS, Wright JT. Can symptomatology help in the 245 diagnosis of endometriosis? Findings from a national case-control study--Part 1. 246 BJOG. 2008 Oct;115(11):1382–91. 247 18. Agarwal SK, Chapron C, Giudice LC, Laufer MR, Leyland N, Missmer SA, et al. Clinical 248 diagnosis of endometriosis: a call to action. Am J Obstet Gynecol. 2019 Apr 249 1;220(4):354.e1-354.e12. 250 19. Soliman AM, Fuldeore M, Snabes MC. Factors Associated with Time to Endometriosis 251 Diagnosis in the United States. J Womens Health (Larchmt). 2017 Jul 1;26(7):788–97. 252 20. Saridotan E. Endometriosis in teenagers. Women’s Heal. 2015;11(5):705–9. 253 21. Nisenblat V, Bossuyt PMM, Shaikh R, Farquhar C, Jordan V, Scheffers CS, et al. Blood 254 biomarkers for the non-invasive diagnosis of endometriosis. Cochrane database Syst 255 Rev. 2016 May 1;2016(5). 256 22. Nisenblat V, Bossuyt PMM, Farquhar C, Johnson N, Hull ML. Imaging modalities for 257 the non-invasive diagnosis of endometriosis. Cochrane database Syst Rev. 2016 Feb 258 26;2(2). 259 23. Hirsch M, Begum MR, Paniz, Barker C, Davis CJ, Duffy JMN. Diagnosis and 260 management of endometriosis: a systematic review of international and national 261 guidelines. BJOG An Int J Obstet Gynaecol. 2018 Apr 1;125(5):556–64. 262 24. Fuldeore MJ, Soliman AM. Prevalence and Symptomatic Burden of Diagnosed 263 Endometriosis in the United States: National Estimates from a Cross-Sectional Survey 264 of 59,411 Women. Gynecol Obstet Invest. 2017 Sep 1;82(5):453–61. 265 25. Culley L, Law C, Hudson N, Denny E, Mitchell H, Baumgarten M, et al. The social and 266 psychological impact of endometriosis on women’s lives: a critical narrative review. 267 Hum Reprod Update. 2013 Nov;19(6):625–39. 268 26. Matsuzaki S, Canis M, Pouly JL, Rabischong B, Botchorishvili R, Mage G. Relationship 269 between delay of surgical diagnosis and severity of disease in patients with 270 symptomatic deep infiltrating endometriosis. Fertil Steril. 2006 Nov 1;86(5):1314–6. 271 27. Simoens S, Dunselman G, Dirksen C, Hummelshoj L, Bokor A, Brandes I, et al. The 272 burden of endometriosis: costs and quality of life of women with endometriosis and 273 treated in referral centres. Hum Reprod. 2012;27(5):1292–9. 274 28. Gruppo italiano per lo studio dell’endometriosi. Endometriosis: Prevalence and Page 6 of 10 https://mc.manuscriptcentral.com/bmj BMJ 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 Confidential: For Review Only 7 275 anatomical distribution of endometriosis in women with selected gynaecological 276 conditions: Results from a multicentric italian study. Hum Reprod. 1994;9(6). 277 29. Moss KM, Doust J, Homer H, Rowlands IJ, Hockey R, Mishra GD. Delayed diagnosis of 278 endometriosis disadvantages women in ART: a retrospective population linked data 279 study. Hum Reprod. 2021 Nov 18;36(12):3074–82. 280 30. Horne AW, Saunders PTK, Abokhrais IM, Hogg L. Top ten endometriosis research 281 priorities in the UK and Ireland. Lancet (London, England). 2017 Jun 282 3;389(10085):2191–2. 283 31. Burton C, Iversen L, Bhattacharya S, Ayansina D, Saraswat L, Sleeman D. Pointers to 284 earlier diagnosis of endometriosis: a nested case-control study using primary care 285 electronic health records. Br J Gen Pract. 2017 Dec 1;67(665):e816–23. 286 32. Dixon S, McNiven A, Talbot A, Hinton L. Navigating possible endometriosis in primary 287 care: a qualitative study of GP perspectives. Br J Gen Pract. 2021 Sep 1;71(710):e668– 288 76. 289 33. Tian Z, Chang XH, Zhao Y, Zhu HL. Current biomarkers for the detection of 290 endometriosis. Chin Med J (Engl). 2020;133(19):2346–52. 291 34. Guerriero S, Saba L, Ajossa S, Peddes C, Angiolucci M, Perniciano M, et al. Three- 292 dimensional ultrasonography in the diagnosis of deep endometriosis. Hum Reprod. 293 2014;29(6). 294 35. Jenkins S, Olive D. Endometriosis: pathogenetic implications of the anatomic 295 distribution. Obstet Gynecol. 1986;67(3):335–8. 296 36. Redwine DB. Ovarian endometriosis: A marker for more extensive pelvic and 297 intestinal disease. Fertil Steril. 1999;72(2). 298 37. Royal Colleges of Obstetrics and Gynaecology. Diagnostic Laparoscopy (Consent 299 Advice No. 2) [Internet]. [cited 2022 Apr 25]. Available from: 300 https://www.rcog.org.uk/guidance/browse-all-guidance/consent-advice/diagnostic- 301 laparoscopy-consent-advice-no-2/ 302 38. Chapron C, Marcellin L, Borghese B, Santulli P. Rethinking mechanisms, diagnosis and 303 management of endometriosis. Nat Rev Endocrinol 2019 1511. 2019 Sep 304 5;15(11):666–82. 305 39. Kalaitzopoulos DR, Samartzis N, Kolovos GN, Mareti E, Samartzis EP, Eberhard M, et 306 al. Treatment of endometriosis: a review with comparison of 8 guidelines. BMC 307 Womens Health. 2021 Dec 1;21(1). 308 40. Chen I, Veth VB, Choudhry AJ, Murji A, Zakhari A, Black AY, et al. Pre- and postsurgical 309 medical therapy for endometriosis surgery. Cochrane Database Syst Rev. 2020 Nov 310 18;2020(12). 311 41. Zakhari A, Delpero E, McKeown S, Tomlinson G, Bougie O, Murji A. Endometriosis 312 recurrence following post-operative hormonal suppression: a systematic review and 313 meta-analysis. Hum Reprod Update. 2021 Jan 4;27(1):96–107. 314 42. Byrne D, Curnow T, Smith P, Cutner A, Saridogan E, Clark TJ. Laparoscopic excision of 315 deep rectovaginal endometriosis in BSGE endometriosis centres: a multicentre 316 prospective cohort study. BMJ Open. 2018 Apr 1;8(4):e018924. 317 43. Bafort C, Beebeejaun Y, Tomassetti C, Bosteels J, Duffy JMN. Laparoscopic surgery for 318 endometriosis. Cochrane database Syst Rev. 2020 Oct 23;10(10). 319 44. Guo SW. Recurrence of endometriosis and its control. Hum Reprod Update. Page 7 of 10 https://mc.manuscriptcentral.com/bmj BMJ 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 Confidential: For Review Only 8 320 2009;15(4):441–61. 321 45. Rowlands IJ, Abbott JA, Montgomery GW, Hockey R, Rogers P, Mishra GD. Prevalence 322 and incidence of endometriosis in Australian women: a data linkage cohort study. 323 BJOG An Int J Obstet Gynaecol. 2021 Mar 1;128(4):657–65. 324 Page 8 of 10 https://mc.manuscriptcentral.com/bmj BMJ 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 Confidential: For Review Only 9 325 326 How common is it A US cross-sectional survey estimated the prevalence of diagnosed endometriosis at 6.1%(24), with a predominant symptom burden in those aged 18-29. This was corroborated by an Australian study reporting that 6.3% of women aged 40-44 years have confirmed endometriosis (45). More prevalent in certain patient groups (2)  Asymptomatic women - 2 to 11%  Women with infertility - 5 to 50%  Women hospitalised for pelvic pain - 5 to 21%  Women with chronic pelvic pain - 50%–75% 327 What you need to know 1. No non-invasive diagnostic tools are available to identify endometriosis, laparoscopic biopsy of endometriotic lesions remains the gold standard for diagnosis 2. Consider endometriosis in women of reproductive age with abdomino-pelvic pain associated with menstruation, sexual intercourse, urination, defecation, and infertility. 3. Pain from suspected endometriosis can be managed in primary care with initial treatment with hormonal contraceptive methods including LNG-IUS combined with analgesia without laparoscopic confirmation 328 How patients were involved in the creation of this article We asked two people living with endometriosis in the UK for comments on an early draft of this paper. In response to their comments, we revised the case to highlight the fact it often takes several years and many visits for endometriosis to be suspected & investigated. We also sought to highlight the impact of endometriosis on quality of life and the recurrence/ongoing impact after surgical excision. 329 Education into practice  How do you communicate with your patients about their menstrual symptoms?  How do you make a provisional diagnosis of endometriosis?  What are the initial treatments you can offer and how would you adapt these for different patients? 330 331 Figure 1 Page 9 of 10 https://mc.manuscriptcentral.com/bmj BMJ 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 Confidential: For Review Only 10 332 333 334 Reproduced with copyright permission from Horne & Saunders 2019 (28). 335 Page 10 of 10 https://mc.manuscriptcentral.com/bmj BMJ 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-pdf ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

MeSH descriptors

Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (51)

Cited by (19)

Source provenance

europepmc
last seen: 2026-11-22T06:15:05.045840+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-23T06:07:57.315420+00:00
unpaywall
last seen: 2026-11-19T08:49:44.633026+00:00
License: CC0 · commercial use OK